Literature DB >> 30700189

Postpartum blood pressure patterns in severe preeclampsia and normotensive pregnant women following abdominal deliveries: a cohort study.

Nnabuike C Ngene1, Jagidesa Moodley2.   

Abstract

Objective: To determine blood pressure (BP) patterns in the immediate postpartum period in preeclampsia with severe features (sPE) and normotensive pregnant women who had cesarean deliveries (CD).Study design: The BP levels of two groups comprising 50 sPE and 90 normotensive pregnant women who had CD were measured before delivery and on days 0-3 postpartum at four time points (05:00, 08:00, 14:00, and 22:00). Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) were measured in the maternal serum ≤48 h before delivery.
Results: Antihypertensive therapy was administered to 98, 96, 82, 78, and 56% of sPE antepartum and on postpartum days 0-3, respectively. De novo postpartum hypertension (BP ≥ 140/90 mmHg) occurred in 24.4% (22/90) of the normotensive group but only one required antihypertensive therapy. The occurrence of de novo postpartum hypertension was associated with maternal weight before delivery ≥ 84.5 kg (relative risks (RR) 2.6, CI 95% 1.2-5.8, p = .017), and body mass index before delivery ≥ 33.3 kg/m2 (RR 2.9, CI 95% 1.3-6.4, p = .008). In sPE, the BP decreased between predelivery period and postpartum day 0. From days 1 to 3 postpartum, there was a continuous increase in the daily mean BPs in both groups, with average daily increments (systolic/diastolic) being 5.6/4.6 mmHg and 0.6/1.3 mmHg in the sPE and normotensive women, respectively. Patient's group and time had a significant effect on BP, p < .001. Overall, daily mean BPs were higher in the sPE than the normotensive group (p < .001). Perceived stress (p = .022), low birth weight (p = .002), 5 min Apgar score ≤ 6 (p < .001) were significantly higher in the sPE group. sFlt-1/PIGF ratio was high in the hypertensive groups: sPE versus normotensive group, p < .001; de novo postpartum hypertension versus normotensives group that remained normotensive, p = .102.
Conclusion: Postpartum BP and antihypertensive requirements are important considerations in managing sPE and normotensive pregnancies. sPE is associated with increased maternal stress and poor perinatal outcomes.

Entities:  

Keywords:  Caesarean delivery; perceived stress scale; perinatal outcomes; postpartum hypertension; preeclampsia with severe features

Mesh:

Substances:

Year:  2019        PMID: 30700189      PMCID: PMC7193714          DOI: 10.1080/14767058.2019.1569621

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  34 in total

Review 1.  A review of the management of eclampsia: practical issues.

Authors:  J Moodley; G Kalane
Journal:  Hypertens Pregnancy       Date:  2006       Impact factor: 2.108

Review 2.  The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.

Authors:  Mark A Brown; Laura A Magee; Louise C Kenny; S Ananth Karumanchi; Fergus P McCarthy; Shigeru Saito; David R Hall; Charlotte E Warren; Gloria Adoyi; Salisu Ishaku
Journal:  Pregnancy Hypertens       Date:  2018-05-24       Impact factor: 2.899

3.  Hypertension in the puerperium.

Authors:  B N Walters; T Walters
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

Review 4.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

5.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.

Authors:  Laura A Magee; Anouk Pels; Michael Helewa; Evelyne Rey; Peter von Dadelszen
Journal:  J Obstet Gynaecol Can       Date:  2014-05

6.  Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo.

Authors:  Leiv Arne Rosseland; Tor Hugo Hauge; Guro Grindheim; Audun Stubhaug; Eldrid Langesæter
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

Review 7.  Prevention and treatment of postpartum hypertension.

Authors:  Laura Magee; Peter von Dadelszen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

8.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Authors:  Vera Regitz-Zagrosek; Jolien W Roos-Hesselink; Johann Bauersachs; Carina Blomström-Lundqvist; Renata Cífková; Michele De Bonis; Bernard Iung; Mark Richard Johnson; Ulrich Kintscher; Peter Kranke; Irene Marthe Lang; Joao Morais; Petronella G Pieper; Patrizia Presbitero; Susanna Price; Giuseppe M C Rosano; Ute Seeland; Tommaso Simoncini; Lorna Swan; Carole A Warnes
Journal:  Eur Heart J       Date:  2018-09-07       Impact factor: 29.983

9.  Global Pregnancy Collaboration symposium: Prepregnancy and very early pregnancy antecedents of adverse pregnancy outcomes: Overview and recommendations.

Authors:  James M Roberts; Christopher W G Redman
Journal:  Placenta       Date:  2017-07-19       Impact factor: 3.481

10.  Making stillbirths visible: a systematic review of globally reported causes of stillbirth.

Authors:  H E Reinebrant; S H Leisher; M Coory; S Henry; A M Wojcieszek; G Gardener; R Lourie; D Ellwood; Z Teoh; E Allanson; H Blencowe; E S Draper; J J Erwich; J F Frøen; J Gardosi; K Gold; S Gordijn; A Gordon; Aep Heazell; T Y Khong; F Korteweg; J E Lawn; E M McClure; J Oats; R Pattinson; K Pettersson; D Siassakos; R M Silver; Gcs Smith; Ö Tunçalp; V Flenady
Journal:  BJOG       Date:  2017-11-29       Impact factor: 6.531

View more
  2 in total

1.  The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.

Authors:  Nnabuike Chibuoke Ngene; Jagidesa Moodley; Thajasvarie Naicker
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

2.  Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period.

Authors:  Nnabuike Chibuoke Ngene; Jagidesa Moodley
Journal:  Pan Afr Med J       Date:  2020-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.